Zachary Abbott

Dr. Zachary Abbott


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Vaccine
Verified
Journal Article
Closed access
MMMarta L. Marthas
Marta L. Marthas
KRKoen K.A. Van Rompay
Koen K.A. Van Rompay
ZAZachary Abbott
Zachary Abbott
PEPatricia Earl
Patricia Earl
LBLinda Buonocore-Buzzelli
Linda Buonocore-Buzzelli
KAKristina Abel
Kristina Abel

3 November 2019 in Journal of Toxicology
Verified
Journal Article
Open access
PDF file
BNB. Appala Naidu
B. Appala Naidu
KKKamala Kannan
Kamala Kannan
DKD. P. Santhosh Kumar
D. P. Santhosh Kumar
JOJohn W. K. Oliver
John W. K. Oliver
ZAZachary Abbott
Zachary Abbott
A 90-day repeated-dose oral toxicological evaluation was conducted according to GLP and OECD guidelines on lyophilized spores of the novel genetically modified strainB. subtilisZB183. Lyophilized spores at doses of 109, 1010, and 1011 CFU/kg body weight/day were administered by oral gavage to Wistar rats for a period of 90 consecutive days.B. subtilisZB183 had no effects on clinical signs, mortality, ophthalmological examinations, functional observational battery, body weights, body weight gains and food consumption in both sexes. There were no test item-related changes observed in haematology, coagulation, urinalysis, thyroid hormonal analysis, terminal fasting body weights, organ weights, gross pathology and histopathology. A minimal increase in the plasma albumin level was observed at 1010and 1011 CFU/kg/day doses without an increase in total protein in males or females and was considered a nonadverse effect. The “No Observed Adverse Effect Level (NOAEL)” is defined at the highest dose of 1011 CFU/kg body weight/day for lyophilizedB. subtilisZB183 Spores under the test conditions employed.

1 July 2015 in mBio
Verified
Journal Article
Open access
PDF file
ZAZachary Abbott
Zachary Abbott
HYHelen Yakhnin
Helen Yakhnin
PBPaul Babitzke
Paul Babitzke
MSMichele S Swanson
Michele S Swanson
Critical to microbial versatility is the capacity to express the cohort of genes that increase fitness in different environments. Legionella pneumophila occupies extensive ecological space that includes diverse protists, pond water, engineered water systems, and mammalian lung macrophages. One mechanism that equips this opportunistic pathogen to adapt to fluctuating conditions is a switch between replicative and transmissive cell types that is controlled by the broadly conserved regulatory protein CsrA. A striking feature of the legionellae surveyed is that each of 14 strains encodes 4 to 7 csrA -like genes, candidate regulators of distinct fitness traits. Here we focus on the one csrA paralog ( lpg1593 ) that, like the canonical csrA , is conserved in all 14 strains surveyed. Phenotypic analysis revealed that long-term survival in tap water is promoted by the lpg1593 locus, which we name csrR (for “ Csr A-similar protein for r esilience”). As predicted by its GGA motif, csrR mRNA was bound directly by the canonical CsrA protein, as judged by electromobility shift and RNA-footprinting assays. Furthermore, CsrA repressed translation of csrR mRNA in vivo , as determined by analysis of csrR-gfp reporters, csrR mRNA stability in the presence and absence of csrA expression, and mutation of the CsrA binding site identified on the csrR mRNA. Thus, CsrA not only governs the transition from replication to transmission but also represses translation of its paralog csrR when nutrients are available. We propose that, during prolonged starvation, relief of CsrA repression permits CsrR protein to coordinate L. pneumophila 's switch to a cell type that is resilient in water supplies. IMPORTANCE Persistence of L. pneumophila in water systems is a public health risk, and yet there is little understanding of the genetic determinants that equip this opportunistic pathogen to adapt to and survive in natural or engineered water systems. A potent regulator of this pathogen's intracellular life cycle is CsrA, a protein widely distributed among bacterial species that is understood quite well. Our finding that every sequenced L. pneumophila strain carries several csrA paralogs—including two common to all isolates—indicates that the legionellae exploit CsrA regulatory switches for multiple purposes. Our discovery that one paralog, CsrR, is a target of CsrA that enhances survival in water is an important step toward understanding colonization of the engineered environment by pathogenic L. pneumophila .

17 October 2012
Verified
Book Chapter
Closed access
PDF file
ABAndrew Bryan
Andrew Bryan
ZAZachary Abbott
Zachary Abbott
MSMichele S. Swanson
Michele S. Swanson

7 November 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CHChandler Hassan-Casarez
Chandler Hassan-Casarez
VRValerie Ryan
Valerie Ryan
BSBentley M. Shuster
Bentley M. Shuster
JOJohn W. K. Oliver
John W. K. Oliver
ZAZachary Abbott
Zachary Abbott
We have addressed critical challenges in probiotic design to develop a commercially viable bacterial strain capable of removing the intestinal toxin, acetaldehyde. In this study, we report the engineering of the hag locus, a σD-dependent flagellin expression site, as a stable location for robust enzyme production. We demonstrate constitutive gene expression in relevant conditions driven by the endogenous hag promoter, following a deletion of the gene encoding a post-translational regulator of σD, FlgM, and a point mutation to abrogate the binding of the translational inhibitor CsrA. Reporter constructs demonstrate activity at the hag locus after germination, with a steady increase in heterologous expression throughout outgrowth and vegetative growth. To evaluate the chassis as a spore-based probiotic solution, we identified the physiologically relevant ethanol metabolic pathway and the subsequent accumulation of gut-derived acetaldehyde following alcohol consumption. We integrated a Cupriavidus necator aldehyde dehydrogenase gene (acoD) into the hag locus under the control of the flagellin promoter and observed a rapid reduction in acetaldehyde levels in gut-simulated conditions post-germination. This work demonstrates a promising approach for the development of genetically engineered spore-based probiotics.

1 September 2012 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
KRKoen K.A. Van Rompay
Koen K.A. Van Rompay
DBDarius Babusis
Darius Babusis
ZAZachary Abbott
Zachary Abbott
YGYongzhi Geng
Yongzhi Geng
KJKartika Jayashankar
Kartika Jayashankar
ARAdrian S. Ray
Adrian S. Ray
To compare tissue-based pharmacokinetics and efficacy of oral tenofovir disoproxyl fumarate (TDF) versus subcutaneous tenofovir (TFV), macaques were treated for 2 weeks starting 1 week after simian immunodeficiency virus inoculation. Despite lower plasma TFV levels in the oral TDF arm, similar TFV diphosphate levels and antiviral activities were measured in lymphoid cells of most tissues. In intestinal tissues, however, oral TDF resulted in higher active drug levels, associated with lower virus levels and better immune preservation.